|
|||||
|
|
COVID-19–Associated Fusobacterium nucleatum Bacteremia,Belgium |
|
| Authors: | Louis Wolff Delphine Martiny Vronique Yvette Miendje Deyi Evelyne Maillart Philippe Clevenbergh Nicolas Dauby |
| Institution: | Université Libre de Bruxelles, Brussels, Belgium (L. Wolff, D. Martiny, V.Y. Miendje Deyi, E. Maillart, P. Clevenbergh, N. Dauby);Saint-Pierre University Hospital Brussels, Brussels (L. Wolff, N. Dauby);Université de Mons, Mons, Belgium (D. Martiny);Laboratoire Hospitalier Universitaire de Bruxelles–Universitair Laboratorium Brussel, Brussels, (D. Martiny, V.Y. Miendje Deyi);Brugmann University Hospital, Brussels (E. Maillart, P. Clevenbergh) |
| Abstract: | We report 4 cases of Fusobacterium nucleatum bacteremia associated with coronavirus disease (COVID-19). Three cases occurred concomitantly with COVID-19 diagnosis; 1 occurred on day 15 of intensive care. None of the patients had known risk factors for F. nucleatum bacteremia. F. nucleatum infection could represent a possible complication of COVID-19. |
| Keywords: | Fusobacterium nucleatum bacteremia bacteria tocilizumab respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS COVID-19 coronavirus disease zoonoses viruses coronavirus |